Dr Agarwal's Health (AGARWALEYE) | Stock Overview & Key Data
Dr Agarwal's Health Performance Comparison
Stock Range
Today's Range
Low: ₹482.90
High: ₹509.30
on October 7, 2025
52 Week Range
Low: ₹327.00
High: ₹515.00
on May 30, 2025
on October 1, 2025
All-Time High: ₹515.00 on October 1, 2025
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR158.0B
EPS
3.20
P/E Ratio (TTM)
156.13
Forward P/E
89.83
P/B Ratio
8.45
PEG Ratio
N/A
Div. Yield
N/A
ROE
4.33%
Beta
N/A
Debt to Equity
49.87
Financial Highlights
Profitability
Gross Margin
43.48%
Operating Margin
13.32%
Profit Margin
5.66%
Returns and Earnings
Return on Assets (TTM)
2.27%
Return on Equity (TTM)
4.33%
EBITDA
INR4.9B
Net Income (TTM)
INR1.0B
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR56.82
Quarterly Revenue Growth (YoY)
20.80%
Quarterly Earnings Growth (YoY)
150.80%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Dr Agarwal's Health AGARWALEYE | 157.95B Mid-cap | -1.67% | 14.06% | 15.16% | 17.52% | 22.10% | 21.97% | 21.97% | 21.97% |
| Poly Medicure POLYMED | 192.37B Mid-cap | -1.88% | -5.98% | -14.48% | -4.87% | -29.19% | -19.05% | 102.62% | 270.23% |
| Laxmi Dental LAXMIDENTL | 18.40B Small-cap | 4.48% | -0.07% | -20.81% | -9.92% | -39.45% | -35.16% | -35.16% | -35.16% |
| Tarsons Products TARSONS | 16.04B Small-cap | -2.55% | -6.56% | -21.52% | -12.15% | -26.13% | -31.27% | -62.66% | -63.39% |
| Prevest Denpro PREVEST | 6.60B Small-cap | -0.61% | -2.93% | -6.29% | 12.17% | -10.00% | -8.47% | 36.54% | 103.77% |
| Shree Pacetronix SHREEPAC | 836.43M Small-cap | 3.50% | 23.54% | 139.65% | 217.06% | 79.95% | 41.84% | 203.19% | 1,800.00% |
Ownership & Short Interest
Insider Ownership
75.68%
Institutional Ownership
17.47%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
415K
Average 90-Day Volume
292K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is AGARWALEYE's 52-week high and low?
- In the last 52 weeks, Dr Agarwal's Health reached a high of ₹515.00 (on October 1, 2025) and a low of ₹327.00 (on May 30, 2025).
- What is the market cap and P/E ratio for AGARWALEYE?
- Curious about Dr Agarwal's Health's size and valuation? Its market capitalization stands at 157.95B. When it comes to valuation, the P/E ratio (trailing twelve months) is 156.13, and the forward P/E (looking ahead) is 89.83.
- Does AGARWALEYE pay dividends? If so, what's the yield?
- As for dividends, Dr Agarwal's Health isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Dr Agarwal's Health's main competitors or similar companies to consider before investing?
When looking at Dr Agarwal's Health, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Poly Medicure
POLYMED192.37B Healthcare Medical Instruments & Supplies -19.05% 102.62% Laxmi Dental
LAXMIDENTL18.40B Healthcare Medical Instruments & Supplies -35.16% -35.16% Tarsons Products
TARSONS16.04B Healthcare Medical Instruments & Supplies -31.27% -62.66% Prevest Denpro
PREVEST6.60B Healthcare Medical Instruments & Supplies -8.47% 36.54% Shree Pacetronix
SHREEPAC836.43M Healthcare Medical Instruments & Supplies 41.84% 203.19% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Dr Agarwal's Health Care Ltd? (e.g., ROE, Debt/Equity)
- To get a sense of Dr Agarwal's Health's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 4.33%, the Debt to Equity ratio from the most recent quarter is 49.87, and its Gross Profit Margin stands at 43.48%.
- What is the recent revenue and earnings growth for AGARWALEYE?
- Looking at Dr Agarwal's Health's growth, its revenue over the trailing twelve months (TTM) was INR18B. Compared to the same quarter last year (YoY), quarterly revenue grew by 20.80%, and quarterly earnings saw a YoY growth of 150.80%.
- How much of AGARWALEYE stock is held by insiders and institutions?
- Wondering who owns Dr Agarwal's Health stock? Company insiders (like executives and directors) hold about 75.68% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 17.47%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.